- Moderna CEO Stephane Bancel told Bloomberg that the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors, beyond melanoma.
- Bancel said the recent data leak for the cancer vaccine candidate did not come from Moderna or Merck.
- The source is a Bloomberg video interview on Bloomberg The Close; the report contains no new trial data, dosing, or regulatory timeline.
Quotes
“believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors”
“the recent data leak for the cancer vaccine candidate did not come from either Moderna or Merck”